Skip to content

CYTO

Altamira Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · BM

$0.30
+0.00%
Ask drillr

Latest reported

Last report date
Sep 24, 2024
EPS actual
-$1.99
EPS estimate
-$2.38
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
-369.4%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 24, 2024-$2.38-$1.99Beat 16.60%—
May 16, 2023—-$3.13——
Nov 30, 2022—-$111——
Apr 12, 2022—$8.6K——
Mar 31, 2022—-$115—$157.1K
Jun 30, 2021—-$117——
Mar 31, 2021—-$115——
Sep 17, 2020—-$123——
Apr 16, 2020-$32-$85Miss -165.98%-$57.1K
Mar 31, 2020—-$119——
Aug 15, 2019-$16-$169Miss -958.79%—
Mar 14, 2019—-$497—$1.3M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 16, 2025